Jan Lehmann - Stadtisches Krankenhaus Kiel

基本信息

浏览量：108

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 151 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Quality of Life of Testicular Cancer Survivors Differs According to Applied Adjuvant Treatment and Tumour Type

Julia Heinzelbecker,Karla Kaßmann,Simone Ernst, Pia Meyer-Mabileau,Aleksandra Germanyuk, Miran Zangana,Gudrun Wagenpfeil,Carsten H. Ohlmann, Maximilian Cohausz,Michael Stöckle,Jan Lehmann

Journal of Cancer Survivorship（2024）

引用0浏览0WOS引用

Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis

Nadia Quignot,Heng Jiang, Indraraj Umesh Doobaree,Jan Lehmann,Ola Ghatnekar

CLINICOECONOMICS AND OUTCOMES RESEARCH（2023）

引用1浏览0WOS引用

Adjuvant Vs. Progression-Triggered Treatment with Gemcitabine in Platinum-Ineligible High-Risk Bladder Cancer Patients: Long-term Follow-Up of a Randomized Phase 3 Trial

Julia Heinzelbecker,Natalie Spieler,Michael Kuehn, Claus Fischer,Bjoern Volkmer, Friedrich von Rundstedt,Peter Albers,Eduard Becht,Andreas Bannowsky, H. Matthias Weber,Rainer Hofmann,Markus Mueller,Sigrun Langbein,Gabriel Steiner,Margitta Retz, Joern Karmradt,Gudrun Wagenpfeil,Stefan Wellek,Jan Lehmann,Michael Stoeckle

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS（2023）

引用0浏览0WOS引用

Treatment Patterns and Outcomes of BCG-treated Non-Muscle Invasive Bladder Cancer Patients in Germany

Indraraj Umesh Doobaree,Nadia Quignot,Heng Jiang,Jan Lehmann,Artak Khachatryan,Ola Ghatnekar

openalex（2023）

引用0浏览0引用

Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials

Sarah Burdett,D. J. Fisher,C. L. Vale,J. F. Tierney,N. W. Clarke,M. K. B. Parmar,C. N. Sternberg,M. Stoeckle,J. Lehmann,U. E. Studer,R. W. Sonntag,F. M. Torti,S. Groshen, A. V. Bono,P. J. Goebell, F. Cognetti,R. J. Cote,L. Collette,A. I. Rolevich,A. G. Zhegalik

EUROPEAN UROLOGYno. 1 (2022): 50-61

引用63浏览0WOS引用

Einflussfaktoren Bei Der Wahl Der Androgendeprivationstherapie Für Patienten Mit Hormonsensitiven Prostatakarzinom

Lehmann J.,Kluike C. W.,Haider A.,Haider K. S, Baumann S., Flesch M., Gedamke M., Kägebein D.

Der Urologe（2021）

引用3浏览0WOS引用

Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS"

Marc-Oliver Grimm,Antoine G. van der Heijden,Marc Colombel,Tim Muilwijk,Luis Martinez-Pineiro,Marko M. Babjuk,Levent N. Turkeri,Joan Palou,Anup Patel,Anders S. Bjartell,Christien Caris,Raymond G. Schipper,Wim P. J. Witjes, Joerg Horstmann,Stefan Machtens, Eberhard Mumperow, Andreas Al Ghazal, Thomas Pulte,Michael Stephan-Odenthal,Georgios Gakis,Mario Kramer,Dirk Zaak,Bernd Schmitz-Draeger, Holger Schreier,Jan Lehmann, Torsten Werner,Joerg Klier,Jan Marin, Wolfgang Rulf,Eva Hellmis,Andreas Schneider, Spiegelhalder,Manfred Wirth,Theodor Klotz,Henrik Suttmann,Michael Siebels, Gerd Rodemer, Robert Rudolph,Roger Zillmann, M. de Bruin, S. Bos,R. van Moorselaar,T. de Reijke,J. Boormans, B. Wijsman,H. H. E. van Melick,E. van Boven,R. P. Meijer,A. G. van der Heijden,H. Vergunst,E. te Slaa, A. M. Leliveld-Kors,Alain Ruffion,Christian Pfister,Morgan Roupret,Jacques Irani,Gabriel Stoica,Siska Van Bruwaene,Filip Ameye,Harm Arentsen,Steven Joniau,Pastora Beardo

EUROPEAN UROLOGY（2020）

引用79浏览0WOS引用

CARD-Studie – Bedeutung Für Die Therapie Des Fortgeschrittenen Prostatakarzinoms

Axel S. Merseburger,Andreas Bannowsky,Klaus Becker,Carsten Bokemeyer,Rolf Eichenauer,Jan Lehmann,Gerald Mickisch,Thomas Steuber,Gunhild von Amsberg, Tobias von Kügelgen,Christian Wülfing

Aktuelle Urologie（2020）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn